Clinical Trial Update: Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study reports expanded pharmacokinetic and pharmacodynamic comparisons between insulin glulisine and insulin aspart in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)
• NovoLog (insulin aspart)

Snippet

Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Diabetes | Phase 1 | Status: COMPLETED